The addition of ezetimibe to statin therapy has been widely demonstrated to significantly reduce low-density lipoprotein cholesterol levels. However, the efficacy of ezetimibe in reducing CV events and its safety has been less investigated. The aim of the current meta-analysis was to report efficacy and safety of ezetimibe from randomized clinical trials.
Safety and efficacy of ezetimibe: A meta-analysis / Savarese, Gianluigi; De Ferrari, Gaetano M; Rosano, Giuseppe M. C; PERRONE FILARDI, Pasquale. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 201:(2015), p. 247-52. [10.1016/j.ijcard.2015.08.103]
Safety and efficacy of ezetimibe: A meta-analysis
PERRONE FILARDI, PASQUALE
2015
Abstract
The addition of ezetimibe to statin therapy has been widely demonstrated to significantly reduce low-density lipoprotein cholesterol levels. However, the efficacy of ezetimibe in reducing CV events and its safety has been less investigated. The aim of the current meta-analysis was to report efficacy and safety of ezetimibe from randomized clinical trials.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
